HK1084891A1 - External preparation for percutaneous administration containing nonsteroidal anti-inflammatory analgesic - Google Patents

External preparation for percutaneous administration containing nonsteroidal anti-inflammatory analgesic

Info

Publication number
HK1084891A1
HK1084891A1 HK06107198.9A HK06107198A HK1084891A1 HK 1084891 A1 HK1084891 A1 HK 1084891A1 HK 06107198 A HK06107198 A HK 06107198A HK 1084891 A1 HK1084891 A1 HK 1084891A1
Authority
HK
Hong Kong
Prior art keywords
external preparation
nonsteroidal anti
percutaneous administration
inflammatory analgesic
administration containing
Prior art date
Application number
HK06107198.9A
Other languages
English (en)
Inventor
K Yoshitake
K Atarashi
T Kuwahara
K Ikesue
M Sakai
Y Hashimoto
K Tsuruda
Original Assignee
Hisamitsu Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisamitsu Pharmaceutical Co filed Critical Hisamitsu Pharmaceutical Co
Publication of HK1084891A1 publication Critical patent/HK1084891A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK06107198.9A 2003-09-03 2006-06-26 External preparation for percutaneous administration containing nonsteroidal anti-inflammatory analgesic HK1084891A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003311904 2003-09-03
PCT/JP2004/012819 WO2005023307A1 (ja) 2003-09-03 2004-09-03 非ステロイド系消炎鎮痛剤を含有する外用経皮製剤

Publications (1)

Publication Number Publication Date
HK1084891A1 true HK1084891A1 (en) 2006-08-11

Family

ID=34269716

Family Applications (2)

Application Number Title Priority Date Filing Date
HK06107198.9A HK1084891A1 (en) 2003-09-03 2006-06-26 External preparation for percutaneous administration containing nonsteroidal anti-inflammatory analgesic
HK11110516.1A HK1155981A1 (en) 2003-09-03 2006-06-26 External preparation for percutaneous administration containing nonsteroidal anti-inflammatory analgesic

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK11110516.1A HK1155981A1 (en) 2003-09-03 2006-06-26 External preparation for percutaneous administration containing nonsteroidal anti-inflammatory analgesic

Country Status (14)

Country Link
US (2) US20070148216A1 (xx)
EP (2) EP1661583B1 (xx)
JP (2) JP4990530B2 (xx)
KR (1) KR101072230B1 (xx)
AT (1) ATE532532T1 (xx)
CY (1) CY1112318T1 (xx)
DK (1) DK1661583T3 (xx)
ES (2) ES2526562T3 (xx)
HK (2) HK1084891A1 (xx)
PL (1) PL1661583T3 (xx)
PT (1) PT1661583E (xx)
SI (1) SI1661583T1 (xx)
TW (1) TWI337086B (xx)
WO (1) WO2005023307A1 (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI341736B (en) 2003-12-26 2011-05-11 Hisamitsu Pharmaceutical Co Anti-infammatory adhesive preparations
EP1767218B1 (en) * 2004-06-15 2016-08-10 Hisamitsu Pharmaceutical Co., Inc. Antiinflammatory and analgesic preparation for external use
ES2370511T3 (es) * 2005-02-25 2011-12-19 Hisamitsu Pharmaceutical Co., Inc. Preparado transdérmico para uso externo que contiene un agente analgésico/antiinflamatorio no esteroideo.
JP2010059136A (ja) * 2008-09-08 2010-03-18 Shiseido Co Ltd 日焼け止め化粧料
WO2013035850A1 (ja) * 2011-09-08 2013-03-14 株式会社 ケイ・エム トランスダーム 経皮吸収製剤
CN102579487A (zh) * 2012-01-29 2012-07-18 中国人民解放军第四军医大学 一种兼具镇痛、抗炎和抗菌的药物组合物
JP5584379B2 (ja) * 2012-06-20 2014-09-03 久光製薬株式会社 経皮吸収促進剤、及びそれを含む貼付剤
WO2014159798A1 (en) 2013-03-13 2014-10-02 Avery Dennison Corporation Improving adhesive properties
WO2015025935A1 (ja) 2013-08-23 2015-02-26 久光製薬株式会社 パップ剤及びその製造方法
BR112016017949B1 (pt) * 2014-02-27 2023-02-07 Hisamitsu Pharmaceutical Co., Inc Emplastro de gel contendo cetoprofeno
BR112017013255B1 (pt) * 2014-12-22 2022-08-09 Hisamitsu Pharmaceutical Co., Inc Cataplasma
CN107362368A (zh) * 2017-07-30 2017-11-21 赵爱良 一种脐贴膏药用基质及其制备方法
US10821658B2 (en) 2018-07-24 2020-11-03 Xerox Corporation Conductive three-dimensional articles
US11903915B2 (en) 2019-02-14 2024-02-20 Hisamitsu Pharmaceutical Co., Inc. Poultice
EP4360630A1 (en) * 2021-09-27 2024-05-01 Hisamitsu Pharmaceutical Co., Inc. Method for inhibiting generation of diclofenac indolinones
WO2023048192A1 (ja) * 2021-09-27 2023-03-30 久光製薬株式会社 ジクロフェナクインドリノン体の生成を抑制する方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5399316A (en) 1977-02-04 1978-08-30 Sanpo Seiyaku Kk Stbilyzing method of leserpine preparation
JPS5622711A (en) 1979-08-01 1981-03-03 Pola Chem Ind Inc Cosmetic prevented from photooxidizing
JPS60155111A (ja) 1983-10-20 1985-08-15 Hisamitsu Pharmaceut Co Inc 安定なケトプロフェン含有外用経皮製剤
US5000945A (en) * 1986-04-22 1991-03-19 Ajinomoto Co., Inc. Method of stabilizing a UVB absorbing compound, a stabilized UV absorber, and a cosmetic composition containing the same
LU87030A1 (fr) * 1987-10-28 1989-05-08 Oreal Utilisation en cosmetique de nouvelles substances a titre de reflecteurs du rayonnement infrarouge,compositions cosmetiques les contenant et leur utilisation pour la protection de l'epiderme humain contre le rayonnement infrarouge
DE69228313T2 (de) * 1991-08-30 1999-09-23 Hisamitsu Pharmaceutical Co., Inc. Entzündungshemmendes, analgetisches pflaster
JP3661706B2 (ja) * 1993-10-28 2005-06-22 三省製薬株式会社 皮膚外用剤
JPH09151108A (ja) * 1995-11-30 1997-06-10 Kose Corp 油中水型乳化化粧料
JPH09169658A (ja) 1995-12-19 1997-06-30 Pola Chem Ind Inc 抗炎症皮膚外用剤
JP3537622B2 (ja) * 1996-02-26 2004-06-14 株式会社資生堂 紫外線吸収性組成物
KR20010013377A (ko) * 1997-06-04 2001-02-26 데이비드 엠 모이어 마일드한 잔류성 항균 조성물
JP3896579B2 (ja) * 1998-02-27 2007-03-22 味の素株式会社 紫外線吸収性組成物
JPH11343224A (ja) * 1998-05-29 1999-12-14 Pola Chem Ind Inc サンケア化粧用の組成物
US5989528A (en) * 1998-07-30 1999-11-23 The Procter & Gamble Company Sunscreen compositions
JP2000136122A (ja) 1998-10-28 2000-05-16 Kose Corp 皮膚外用剤
US6967023B1 (en) * 2000-01-10 2005-11-22 Foamix, Ltd. Pharmaceutical and cosmetic carrier or composition for topical application
AU784779B2 (en) * 2000-03-17 2006-06-15 Hisamitsu Pharmaceutical Co., Inc. Ultraviolet-shielding adhesive preparation
US6914169B1 (en) * 2000-05-19 2005-07-05 Hisamitsu Pharmaceutical., Inc. Patch agent
ATE300281T1 (de) * 2001-02-22 2005-08-15 Menarini France S A Entzündungshemmende arzneizubereitungen enthaltend ketoprofen
FR2826264B1 (fr) * 2001-06-26 2005-03-04 Oreal Solubilisation de derives 1,3,5 triazine par des esters n-acyles d'acide amine
JP2003012508A (ja) * 2001-06-28 2003-01-15 Lion Corp 外用貼付剤
FR2827511B1 (fr) * 2001-07-19 2003-10-17 Oreal Composition autobronzante contenant un ester n-acyle d'acide amine et un agent autobronzant
US6440402B1 (en) * 2001-12-14 2002-08-27 Avon Products, Inc. Photostable sunscreen compositions and methods of stabilizing
JP4167834B2 (ja) * 2002-01-25 2008-10-22 久光製薬株式会社 粘着剤およびこれを用いてなる貼付製剤
TWI341736B (en) * 2003-12-26 2011-05-11 Hisamitsu Pharmaceutical Co Anti-infammatory adhesive preparations

Also Published As

Publication number Publication date
KR20070028278A (ko) 2007-03-12
EP1661583B1 (en) 2011-11-09
US20070148216A1 (en) 2007-06-28
US20100240758A1 (en) 2010-09-23
DK1661583T3 (da) 2012-02-27
JP4990530B2 (ja) 2012-08-01
PL1661583T3 (pl) 2012-04-30
SI1661583T1 (sl) 2012-01-31
JPWO2005023307A1 (ja) 2007-11-01
KR101072230B1 (ko) 2011-10-12
EP2366407B1 (en) 2014-11-12
JP5551630B2 (ja) 2014-07-16
PT1661583E (pt) 2012-02-20
HK1155981A1 (en) 2012-06-01
TW200517138A (en) 2005-06-01
WO2005023307A1 (ja) 2005-03-17
EP2366407A1 (en) 2011-09-21
TWI337086B (en) 2011-02-11
EP1661583A1 (en) 2006-05-31
JP2011121980A (ja) 2011-06-23
ATE532532T1 (de) 2011-11-15
ES2376551T3 (es) 2012-03-14
CY1112318T1 (el) 2015-12-09
EP1661583A4 (en) 2009-07-29
ES2526562T3 (es) 2015-01-13

Similar Documents

Publication Publication Date Title
HK1084891A1 (en) External preparation for percutaneous administration containing nonsteroidal anti-inflammatory analgesic
IL166483A0 (en) Pharmaceutical compositions containing ciclesonideand an antihistamine
WO2005020913A3 (en) Formulations, conjugates, and combinations of drugs for the treatment of neoplasms
EP2409569A3 (en) Method for administering GLP-1 molecules
AU2002335138A1 (en) Intravascular administration set needle safety device
EP1399414A4 (en) SUBSTITUTED TETRACYCLINE COMPOUNDS FOR THE TREATMENT OF MALARIA
ATE478840T1 (de) 3-aminoazetidinderivate enthaltende pharmazeutische zusammensetzungen, diese derivate und deren herstellung
PL372084A1 (en) 8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient
AU2003244890A1 (en) An infusion device for medical use.
NO20053224D0 (no) Patient controlled drug administration device.
IL164699A0 (en) Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
NO20054214D0 (no) Iminoeterderivatforbindelser og legemidler inneholdende forbindelsene som den aktive bestanddel
AU2001228811A1 (en) Nitrogen-containing 5-membered cyclic compounds and drugs containing these compounds as the active ingredient
AU2003228400A1 (en) Medicant package
DE60203537D1 (de) 5ht1-rezeptoragonist enthaltendes arzneimittel
EP1509220A4 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF SEBORRHEA CONTAINING 4-HYDROXY-5-METHOXY-4- 2-METHYL-3- (3-METHYL-2-BUTENYL) -2-OXIRANYL -1-OXASPIRO 2,5 OCTANE-6-ONE
AU2001258443A1 (en) Drug delivery device, especially for the delivery of gestodene
GB0001315D0 (en) Organic compounds
WO2003061572A8 (en) Anti-inflammatory formulations
AU2369801A (en) Pharmaceutical composition for transdermally administering hormones with an additive that enhances permeation
DE502004003170D1 (de) Schmelzformulierte, multipartikuläre orale darreichungsform enthaltend clavulansäure
IL157356A0 (en) Pharmaceutical compositions containing a taxane derivative at a low dosage
WO2002024210A3 (en) Halogen compounds for use in medicine
ITTO20050301A1 (it) Formulazioni liquide orali contenenti citalopram
NO20030474D0 (no) Demens-legemiddel som inneholder 2-aryl-8- oksodihydropurinderivater som denaktive bestanddel

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20240830